Latiglutenase as a Treatment for Celiac Disease
Clinical trial NCT03585478 · COMPLETED
Trial details
- NCT number
- NCT03585478
- Sponsor
- Immunogenics, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-01
- Primary completion
- 2021-01-22
- Enrollment
- 79
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.